336 related articles for article (PubMed ID: 16388358)
1. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL;
Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358
[TBL] [Abstract][Full Text] [Related]
2. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis.
Mancardi GL; Murialdo A; Rossi P; Gualandi F; Martino G; Marmont A; Ciceri F; Schenone A; Parodi RC; Capello E; Comi G; Uccelli A
Mult Scler; 2005 Jun; 11(3):367-71. PubMed ID: 15957523
[TBL] [Abstract][Full Text] [Related]
5. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
[TBL] [Abstract][Full Text] [Related]
6. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
Créange A; Farge-Bancel D
Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
[TBL] [Abstract][Full Text] [Related]
7. Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
Fassas A; Mancardi GL
Autoimmunity; 2008 Dec; 41(8):601-10. PubMed ID: 18958762
[TBL] [Abstract][Full Text] [Related]
8. Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks.
Capello E; Vuolo L; Gualandi F; Van Lint MT; Roccatagliata L; Bonzano L; Pardini M; Uccelli A; Mancardi G
Neurol Sci; 2009 Oct; 30 Suppl 2():S175-7. PubMed ID: 19882370
[TBL] [Abstract][Full Text] [Related]
9. [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].
Saiz A; Blanco Y; Berenguer J; Gómez-Choco M; Carreras E; Arbizu T; Graus F
Neurologia; 2008 Sep; 23(7):405-7. PubMed ID: 18726717
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in multiple sclerosis.
Rogojan C; Frederiksen JL
Acta Neurol Scand; 2009 Dec; 120(6):371-82. PubMed ID: 19785643
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
[TBL] [Abstract][Full Text] [Related]
12. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
Fassas A; Kimiskidis VK
J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem-cell transplantation in multiple sclerosis.
Mancardi G; Saccardi R
Lancet Neurol; 2008 Jul; 7(7):626-36. PubMed ID: 18565456
[TBL] [Abstract][Full Text] [Related]
14. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.
Roccatagliata L; Rocca M; Valsasina P; Bonzano L; Sormani M; Saccardi R; Mancardi G; Filippi M;
Mult Scler; 2007 Sep; 13(8):1068-70. PubMed ID: 17468445
[TBL] [Abstract][Full Text] [Related]
15. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.
Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD
J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311
[TBL] [Abstract][Full Text] [Related]
16. [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: I. The evidences for the use of immunosuppressive agents, plasma exchange and autologous hematopoietic stem cell transplantation].
Callegaro D; Lana-Peixoto MA; Moreira MA; Marchiori PE; Bacheschi LA; Arruda WO; Campos GB; Lino AM; Melo AS; Rocha FC; Ferreira ML; Ataide L; Maciel DR;
Arq Neuropsiquiatr; 2002 Sep; 60(3-B):869-74. PubMed ID: 12364965
[TBL] [Abstract][Full Text] [Related]
17. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.
Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G
Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838
[TBL] [Abstract][Full Text] [Related]
18. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
Fagius J; Lundgren J; Oberg G
Mult Scler; 2009 Feb; 15(2):229-37. PubMed ID: 18805841
[TBL] [Abstract][Full Text] [Related]
19. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
[TBL] [Abstract][Full Text] [Related]
20. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
